Released May 06, 2011
LONDON, OntarioKGK Synergize Inc. launched It Makes Cents" in support of Vitamin Angels. Effective May 1, 2011, KGK is donating a portion of every contract signed for human clinical trials to Vitamin Angels with a goal of reaching 80,000 children and mothers over the next year.
For the last few years, I have been touched by the work that Vitamin Angels does in their fight against malnutrition, and I felt compelled to help," said Najla Guthrie, president and CEO of KGK Synergize Inc. Even though we are a small company, it only takes an incremental change in how we do business to make a big difference in the lives of others. The It Makes Cents initiative is our first step to bringing awareness to issues such as malnutrition and vitamin A deficiency (VAD), which contributes to blindness and under-five child mortality; as well as providing prenatal vitamins to support a womens healthy pregnancy and contribute to the well-being of her infant."
Howard B Schiffer, founder and president of Vitamin Angels, noted, "Vitamin Angels is honored to be working with KGK Synergize. Its commitment to making this world a healthier place is outstanding. Together we are reaching more than 24 million children around the world and in the United States. For these children, the essential nutrients we provide are giving them a chance to lead full and productive lives. We could not do this work without KGK's support."
Vitamin Angels is dedicated to reducing child mortality worldwide by advancing availability, access and use of essential micronutrients, especially vitamin A, to newborns, infants and children under 5 years old. In 2010, Vitamin Angels connected more than 22.5 million children in 43 countries, including the United States, with the vital nutrients they need as a foundation for good health.
KGK conducts human clinical trials for the health nutrition industry and specializes in developing clinical studies that meet FDA/FTC and Health Canada regulations. KGK also offers clinical trial services to assist companies in substantiating claims and provides comprehensive final reports to be submitted to regulatory agencies as is.